Sharh maqola

H19 lncRNA: Roles in tumorigenesis

Soudeh Ghafouri‐FardUrology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IranMohammadhosein EsmaeiliBlood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, IranMohammad TaheriUrogenital Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: [email protected]

2019en

ABI

Annotatsiya

H19 is a long non-coding RNA [lncRNA] which was firstly described as an oncofetal transcript. The imprinted gene is normally expressed from the maternal allele. However, this pattern of imprinting is dysregulated in several cancers leading to aberrant up-regulation of H19 in malignant tissues. Several studies have utilized this aberrant expression pattern to find specific biomarkers for detection of cancer in tumoral tissues or peripheral blood. Moreover, single nucleotide polymorphisms within H19 have been associated with risk of oral squamous cell carcinoma, hepatocellular carcinoma, breast cancer, bladder cancer, gastric cancer and colorectal cancer. Taken together, H19 is regarded as a biomarker for cancer and a putative therapeutic target in these human disorders.

Hali tarjima qilinmagan

Identifikatorlar

DOI: 10.1016/j.biopha.2019.109774

Iqtiboslar va manbalar

3 ta iqtibos0 ta foydalanilgan manba

Koʻrsatkichlar — AkademScholar